Nikhil Pande

Once-a-Week Versus Once-Every-3-Weeks Cisplatin Chemoradiation for Locally Advanced Head and Neck Cancer: A Phase III Randomized Noninferiority Trial

Vanita Noronha, Amit Joshi, Vijay Patil et al. · Journal of Clinical Oncology · 2017 · 337 citations

Medicine, Oncology, Radiation Oncology +14

A randomized phase 3 trial comparing nimotuzumab plus cisplatin chemoradiotherapy versus cisplatin chemoradiotherapy alone in locally advanced head and neck cancer

Vijay Patil, Vanita Noronha, Amit Joshi et al. · Cancer · 2019 · 130 citations

Medicine, Oncology, Radiation Oncology +11

Phase III study of gefitinib or pemetrexed with carboplatin in EGFR-mutated advanced lung adenocarcinoma

Vijay Patil, Vanita Noronha, Amit Joshi et al. · ESMO Open · 2017 · 71 citations · Full text

Medicine, Oncology, Pharmacology +17

ROS1 mutation non-small cell lung cancer—access to optimal treatment and outcomes

Amit Joshi, Nikhil Pande, Vanita Noronha et al. · ecancermedicalscience · 2019 · 34 citations · Full text

Medicine, Oncology, Pharmacology +15

Phase III randomized trial comparing weekly versus three-weekly (W3W) cisplatin in patients receiving chemoradiation for locally advanced head and neck cancer.

Vanita Noronha, Amit Joshi, Vijay Patil et al. · Journal of Clinical Oncology · 2017 · 26 citations

Medicine, Radiation Oncology, Cancer Drug Toxicity Management +13